Tirzepatide
TIRZE-PAP
Eli Lilly · Phase 2/3 · Not yet recruiting · Enrollment 256
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Continuous Positive Airway Pressure (CPAP) | n/r | n/r | n/r | n/r |
| Tirzepatide | n/r | n/r | n/r | n/r |
Not shown
- Continuous Positive Airway Pressure (CPAP): endpoint not reported
- Tirzepatide: endpoint not reported